Showing results (1521-1530 of 1,955) with videos related to

Sort By:
Pageof 196
Journal of Thrombosis and Thrombolysis|May 17, 2022
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumGeoffrey D Barnes, Allison Burnett, Arthur Allen, et al.
Molecular Biology and Evolution|September 14, 2022
VIVID: A Web Application for Variant Interpretation and Visualization in Multi-dimensional AnalysesSwapnil Tichkule, Yoochan Myung, Myo T Naung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
Blood|September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphomaPhilippe Armand, Ann Janssens, Giuseppe Gritti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Oncoimmunology|June 2, 2025
The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 studyRosaria De Filippi, Fortunato Morabito, Giovanni Tripepi, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Investigational New Drugs|August 22, 2014
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinomaNizar M Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, et al.
Pageof 196